Clinical Trials Directory

Trials / Completed

CompletedNCT02140450

Effect of Antiglaucoma Agents on Short Term Intraocular Pressure Fluctuations After Intravitreal Bevacizumab Injection

Short Term Intraocular Pressure Fluctuations After Intravitreal Bevacizumab Injection: the Effect of Pretreatment With Antiglaucoma Agents

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
70 (actual)
Sponsor
Mashhad University of Medical Sciences · Academic / Other
Sex
All
Age
40 Years – 80 Years
Healthy volunteers
Accepted

Summary

To assess the effect of prophylactic antiglaucoma agents in prevention of acute intraocular pressure rise after intravitreal injection.

Detailed description

Acute intraocular pressure elevation after intravitreal injection of bevacizumab was proven.Acute intraocular pressure elevation most probably is volume related and long term intraocular pressure elevation relates to pharmacologic features of the medications which results in anatomic changes in the angle of anterior chamber.Numerous studies found an intraocular pressure elevation right after the injection and quick normalization within maximally 30 minutes.This intraocular pressure elevation which lasts about 30 minutes, can result in irreversible visual loss especially in patients with critical remaining nerve fibers in the optic nerve head, as occurs in glaucomatous patients. Is there any way to prevent or even shorten this time of intraocular pressure elevation? We tried in our study to find a suitable response for a question above, so we used several anti-glaucoma agents (Timolol, Brimonidine, Acetazolamide, Mannitol versus placebo) as a prophylaxis to prevent acute intraocular pressure elevation right after intravitreal bevacizumab injection.

Conditions

Interventions

TypeNameDescription
DRUGTimolol2 drops of timolol, 10 minutes apart, 1-2 hours before intravitreal injection
DRUGBrimonidineBrimonidine eyedrop, 2 drops 5 minutes apart, 1-2 hours before intravitreal injection
DRUGAcetazolamideAcetazolamide tablet, 2 tabs, 2 hours before intravitreal injection
DRUGMannitolIntravenous mannitol, 1.5 gram/kg, 1 hour before intravitreal injection
DRUGPlaceboArtificial tears, 2 drops, 1-2 hours before intravitreal injection

Timeline

Start date
2012-02-01
Primary completion
2014-01-01
Completion
2014-05-01
First posted
2014-05-16
Last updated
2014-05-16

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT02140450. Inclusion in this directory is not an endorsement.